January 31, 2019
The 2018 Congressional midterm elections are over: the US is back to divided government. And with Democrats controlling the House, and Republicans expanding their majority in the Senate, the US pharma industry could be the number one target for politicians.
0 min read
January 31, 2019
Conversations around drug pricing look set to continue for years – and the resulting pressure will undoubtedly necessitate change. And yet, despite controversies surrounding this thorny issue, we should not forget to celebrate the positive side of pharma: fantastic progress in science and engineering is driving advances in discovery, development and manufacturing, with life-saving – and perhaps industry-changing – results.
0 min read
January 31, 2019
Ups and downs, swings, merry-go-rounds… As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. What can we do? Address the challenges head on and celebrate the successes with verve.
0 min read
January 23, 2019
2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…
0 min read
January 23, 2019
What lies ahead for Gene and Eva in 2019? Cell and gene therapies...
0 min read
January 22, 2019
How a collaborative project aims to cut the cost of gene therapy
0 min read
January 22, 2019
Mimicking the exomes secreted by nasal cells in response to bacteria could boost drug uptake
0 min read
January 22, 2019
Gearing up for 2019, the EMA shares revised guidelines to better protect the environment, and unveils plans to protect us all in a health emergency
0 min read
January 22, 2019
Could observation of waltzing therapeutic nanoparticles help determine drug efficacy?
0 min read
